Ampio Pharmaceuticals Securities Settlement

Wang, et al. v. Ampio Pharmaceuticals, et al., Civil Action No. 1:22-cv-02105-WJM-MEH
United States District Court for the District of Colorado

Welcome to the Settlement Website for
Ampio Pharmaceuticals Securities Settlement

If you purchased or otherwise acquired Ampio’s common stock between December 29, 2020 and August 2, 2022, inclusive, and were damaged thereby, then you may be entitled to a payment from a class action settlement.

A federal court authorized this Website.

  • The purpose of this website is to inform you of the pendency of the securities class action in United States federal court (the “Action”), the proposed settlement of the Action (the “Settlement”), and a hearing to be held by the Court to consider: (i) whether the Settlement should be approved; (ii) whether the proposed plan for allocating the proceeds of the Settlement (the “Plan of Allocation”) should be approved; and (iii) whether Lead Counsel’s Fee and Expense Application should be approved. The Notice describes important rights you may have and what steps you must take if you wish to participate in the Settlement, wish to object, or wish to be excluded from the Settlement Class.
  • On September 24, 2024, the Court preliminarily approved the Settlement. If given final approval by the Court, the proposed Settlement will create a $3,000,000 Settlement Fund, plus any interest or income earned thereon, for the benefit of eligible Settlement Class Members, less any attorneys’ fees, expenses, and costs awarded by the Court, Notice and Administration Expenses, and Taxes.
  • This Settlement resolves claims by Tao Wang and SynWorld Technologies Corporation, Lead Plaintiffs in the Action (“Lead Plaintiffs”), individually and on behalf of each member of the Settlement Class, against Ampio Pharmaceuticals, Inc. (“Ampio”), and Michael A. Martino, Holli Cherevka, Dan Stokely, David Bar-Or, Philip H. Coelho, and Richard B. Giles (the “Individual Defendants,” with Ampio, the “Defendants,” and collectively with Lead Plaintiffs, the “Parties”). Defendants deny all allegations of misconduct. The two sides disagree on whether the investors could have won at trial, and if so, how much money they could have won.
  • Attorneys for Lead Plaintiffs will ask the Court for 28% of the Settlement Fund and up to $75,000 in reimbursement for expenses incurred in prosecuting this lawsuit. Lead Counsel also intends to ask the Court to grant Lead Plaintiffs an award of up to $5,000 for reasonable costs and expenses (including lost wages) directly relating to their representation of the class. If approved by the Court, these amounts (totaling approximately $0.007 per allegedly damaged share) will be paid from the Settlement Fund.
  • The estimated average recovery, after deducting attorneys’ fees and expenses, Administrative costs, and Lead Plaintiffs’ costs and expenses (if approved by the Court), is $0.015 per share).
  • Your legal rights are affected whether you act or do not act. Read the Notice carefully.
  • YOUR LEGAL RIGHTS AND OPTIONS IN THIS SETTLEMENT

    SUBMIT A CLAIM FORM BY JANUARY 13, 2025

    The only way to get a payment. See FAQ 9 for details.

    EXCLUDE YOURSELF BY JANUARY 29, 2025

    Get no payment. This is the only option that, assuming your claim is timely brought, might allow you to ever bring or be part of any other lawsuit against Defendants and/or the other Released Defendant Parties concerning the Released Claims. See FAQ 12 for details.

    OBJECT BY JANUARY 29, 2025

    Write to the Court about why you do not like the Settlement, the proposed Plan of Allocation, Lead Counsel’s application for an award of attorneys’ fees and payment of expenses, and/or an award of reasonable costs and expenses to Lead Plaintiffs. If you object, you will still be a member of the Settlement Class. See FAQ 16 for details.

    GO TO A HEARING ON FEBRUARY 19, 2025, AND FILE A NOTICE OF INTENTION TO APPEAR BY JANUARY 29, 2025

    Ask to speak in Court about the Settlement at the Settlement Hearing. See FAQ 20 for details.

    DO NOTHING

    Get no payment AND give up your rights to bring your own individual action. See FAQ 21 for details.

  • These rights and options - and the deadlines to exercise them - are explained in the Notice.
  • The Court in charge of this case still has to decide whether to approve the Settlement. Payments will be made to all Settlement Class Members who timely submit valid Claim Forms if the Court approves the Settlement and any appeals are resolved and do not reverse the Settlement approval. Please be patient.

Upcoming Important Dates

Claim Deadline

1/13/2025

Exclusion/Opt Out Deadline

1/29/2025

Objection Deadline

1/29/2025

Final Approval Hearing

2/19/2025